| Mr John Roborg Lynch, MD | |
|
9200 W Wisconsin Ave, Department Of Neurology, Milwaukee, WI 53226-3522 | |
| (414) 805-9236 | |
| (414) 805-5252 |
| Full Name | Mr John Roborg Lynch |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 30 Years |
| Location | 9200 W Wisconsin Ave, Milwaukee, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043251648 | NPI | - | NPPES |
| 1043251648 | Medicaid | WI |
| Facility Name | Location | Facility Type |
|---|---|---|
| Naples Community Hospital | Naples, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Virtual Neurology Texas Pllc | 3779910047 | 98 |
| Virtual Neurology Llc | 9830425321 | 106 |
| Piedmont Hospitalist Physicians Llc | 1951299163 | 303 |
| Lee Memorial Health System | 8729996608 | 1022 |
| Nchmd Inc | 9436139565 | 374 |
| Virtual Neurology Texas Pllc | 3779910047 | 98 |
News Archive
One third of the world's population is infected with Mycobacterium tuberculosis (MTB), which leads to tuberculosis (TB), a leading cause of death world-wide. A new discovery, led by a team of researchers from Case Western Reserve University School of Medicine, offers hope for new approaches to the prevention and treatment of TB. The team's discovery of a novel mechanism that may contribute to immune recognition of MTB is published in the September issue of Nature Structural and Molecular Biology.
Canada's pharmaceutical products industry stands out for its strong growth during the 2008-09 recession. This sets it apart from other industries covered in the Winter 2010 edition of The Conference Board of Canada's Canadian Industrial Profile Service - chemicals, plastic and rubber products, non-metallic mineral products, and computer and electronic products, which will take at least a couple of years to return to pre-recession production, revenue and profit levels.
A new position statement on the use of hormone therapy (HT) for menopausal and postmenopausal women from The North American Menopause Society has been published online today in the Society's journal, Menopause.
Euthymics Bioscience, Inc. today will present Phase II clinical data demonstrating that its lead product candidate EB-1010, a next-generation antidepressant, is effective for treating major depressive disorder (MDD) based on multiple standard measures of outcome for depression. EB-1010 also improved measures of anhedonia, a hallmark symptom of MDD, which is characterized by the inability to experience pleasure.
Almost half of U.S. youth who experience violence, abuse or crime have had at least one of their victimizations known to school, police or medical authorities, according to a report in the January issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.
› Verified 9 days ago
| Entity Name | Bronson Methodist Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417961137 PECOS PAC ID: 0244148633 Enrollment ID: O20031208000832 |
News Archive
One third of the world's population is infected with Mycobacterium tuberculosis (MTB), which leads to tuberculosis (TB), a leading cause of death world-wide. A new discovery, led by a team of researchers from Case Western Reserve University School of Medicine, offers hope for new approaches to the prevention and treatment of TB. The team's discovery of a novel mechanism that may contribute to immune recognition of MTB is published in the September issue of Nature Structural and Molecular Biology.
Canada's pharmaceutical products industry stands out for its strong growth during the 2008-09 recession. This sets it apart from other industries covered in the Winter 2010 edition of The Conference Board of Canada's Canadian Industrial Profile Service - chemicals, plastic and rubber products, non-metallic mineral products, and computer and electronic products, which will take at least a couple of years to return to pre-recession production, revenue and profit levels.
A new position statement on the use of hormone therapy (HT) for menopausal and postmenopausal women from The North American Menopause Society has been published online today in the Society's journal, Menopause.
Euthymics Bioscience, Inc. today will present Phase II clinical data demonstrating that its lead product candidate EB-1010, a next-generation antidepressant, is effective for treating major depressive disorder (MDD) based on multiple standard measures of outcome for depression. EB-1010 also improved measures of anhedonia, a hallmark symptom of MDD, which is characterized by the inability to experience pleasure.
Almost half of U.S. youth who experience violence, abuse or crime have had at least one of their victimizations known to school, police or medical authorities, according to a report in the January issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.
› Verified 9 days ago
| Entity Name | Lakeland Hospitals At Niles And St Joseph Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134220031 PECOS PAC ID: 7517929037 Enrollment ID: O20041027001172 |
News Archive
One third of the world's population is infected with Mycobacterium tuberculosis (MTB), which leads to tuberculosis (TB), a leading cause of death world-wide. A new discovery, led by a team of researchers from Case Western Reserve University School of Medicine, offers hope for new approaches to the prevention and treatment of TB. The team's discovery of a novel mechanism that may contribute to immune recognition of MTB is published in the September issue of Nature Structural and Molecular Biology.
Canada's pharmaceutical products industry stands out for its strong growth during the 2008-09 recession. This sets it apart from other industries covered in the Winter 2010 edition of The Conference Board of Canada's Canadian Industrial Profile Service - chemicals, plastic and rubber products, non-metallic mineral products, and computer and electronic products, which will take at least a couple of years to return to pre-recession production, revenue and profit levels.
A new position statement on the use of hormone therapy (HT) for menopausal and postmenopausal women from The North American Menopause Society has been published online today in the Society's journal, Menopause.
Euthymics Bioscience, Inc. today will present Phase II clinical data demonstrating that its lead product candidate EB-1010, a next-generation antidepressant, is effective for treating major depressive disorder (MDD) based on multiple standard measures of outcome for depression. EB-1010 also improved measures of anhedonia, a hallmark symptom of MDD, which is characterized by the inability to experience pleasure.
Almost half of U.S. youth who experience violence, abuse or crime have had at least one of their victimizations known to school, police or medical authorities, according to a report in the January issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.
› Verified 9 days ago
| Entity Name | Lakeland Medical Practices |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538397120 PECOS PAC ID: 1658427042 Enrollment ID: O20090928000216 |
News Archive
One third of the world's population is infected with Mycobacterium tuberculosis (MTB), which leads to tuberculosis (TB), a leading cause of death world-wide. A new discovery, led by a team of researchers from Case Western Reserve University School of Medicine, offers hope for new approaches to the prevention and treatment of TB. The team's discovery of a novel mechanism that may contribute to immune recognition of MTB is published in the September issue of Nature Structural and Molecular Biology.
Canada's pharmaceutical products industry stands out for its strong growth during the 2008-09 recession. This sets it apart from other industries covered in the Winter 2010 edition of The Conference Board of Canada's Canadian Industrial Profile Service - chemicals, plastic and rubber products, non-metallic mineral products, and computer and electronic products, which will take at least a couple of years to return to pre-recession production, revenue and profit levels.
A new position statement on the use of hormone therapy (HT) for menopausal and postmenopausal women from The North American Menopause Society has been published online today in the Society's journal, Menopause.
Euthymics Bioscience, Inc. today will present Phase II clinical data demonstrating that its lead product candidate EB-1010, a next-generation antidepressant, is effective for treating major depressive disorder (MDD) based on multiple standard measures of outcome for depression. EB-1010 also improved measures of anhedonia, a hallmark symptom of MDD, which is characterized by the inability to experience pleasure.
Almost half of U.S. youth who experience violence, abuse or crime have had at least one of their victimizations known to school, police or medical authorities, according to a report in the January issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.
› Verified 9 days ago
| Entity Name | Virtual Neurology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760940167 PECOS PAC ID: 9830425321 Enrollment ID: O20220705001770 |
News Archive
One third of the world's population is infected with Mycobacterium tuberculosis (MTB), which leads to tuberculosis (TB), a leading cause of death world-wide. A new discovery, led by a team of researchers from Case Western Reserve University School of Medicine, offers hope for new approaches to the prevention and treatment of TB. The team's discovery of a novel mechanism that may contribute to immune recognition of MTB is published in the September issue of Nature Structural and Molecular Biology.
Canada's pharmaceutical products industry stands out for its strong growth during the 2008-09 recession. This sets it apart from other industries covered in the Winter 2010 edition of The Conference Board of Canada's Canadian Industrial Profile Service - chemicals, plastic and rubber products, non-metallic mineral products, and computer and electronic products, which will take at least a couple of years to return to pre-recession production, revenue and profit levels.
A new position statement on the use of hormone therapy (HT) for menopausal and postmenopausal women from The North American Menopause Society has been published online today in the Society's journal, Menopause.
Euthymics Bioscience, Inc. today will present Phase II clinical data demonstrating that its lead product candidate EB-1010, a next-generation antidepressant, is effective for treating major depressive disorder (MDD) based on multiple standard measures of outcome for depression. EB-1010 also improved measures of anhedonia, a hallmark symptom of MDD, which is characterized by the inability to experience pleasure.
Almost half of U.S. youth who experience violence, abuse or crime have had at least one of their victimizations known to school, police or medical authorities, according to a report in the January issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.
› Verified 9 days ago
| Entity Name | Virtual Neurology Texas Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467092114 PECOS PAC ID: 3779910047 Enrollment ID: O20231107002601 |
News Archive
One third of the world's population is infected with Mycobacterium tuberculosis (MTB), which leads to tuberculosis (TB), a leading cause of death world-wide. A new discovery, led by a team of researchers from Case Western Reserve University School of Medicine, offers hope for new approaches to the prevention and treatment of TB. The team's discovery of a novel mechanism that may contribute to immune recognition of MTB is published in the September issue of Nature Structural and Molecular Biology.
Canada's pharmaceutical products industry stands out for its strong growth during the 2008-09 recession. This sets it apart from other industries covered in the Winter 2010 edition of The Conference Board of Canada's Canadian Industrial Profile Service - chemicals, plastic and rubber products, non-metallic mineral products, and computer and electronic products, which will take at least a couple of years to return to pre-recession production, revenue and profit levels.
A new position statement on the use of hormone therapy (HT) for menopausal and postmenopausal women from The North American Menopause Society has been published online today in the Society's journal, Menopause.
Euthymics Bioscience, Inc. today will present Phase II clinical data demonstrating that its lead product candidate EB-1010, a next-generation antidepressant, is effective for treating major depressive disorder (MDD) based on multiple standard measures of outcome for depression. EB-1010 also improved measures of anhedonia, a hallmark symptom of MDD, which is characterized by the inability to experience pleasure.
Almost half of U.S. youth who experience violence, abuse or crime have had at least one of their victimizations known to school, police or medical authorities, according to a report in the January issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr John Roborg Lynch, MD 9200 W Wisconsin Ave, Department Of Neurology, Milwaukee, WI 53226-3522 Ph: (414) 805-9236 | Mr John Roborg Lynch, MD 9200 W Wisconsin Ave, Department Of Neurology, Milwaukee, WI 53226-3522 Ph: (414) 805-9236 |
News Archive
One third of the world's population is infected with Mycobacterium tuberculosis (MTB), which leads to tuberculosis (TB), a leading cause of death world-wide. A new discovery, led by a team of researchers from Case Western Reserve University School of Medicine, offers hope for new approaches to the prevention and treatment of TB. The team's discovery of a novel mechanism that may contribute to immune recognition of MTB is published in the September issue of Nature Structural and Molecular Biology.
Canada's pharmaceutical products industry stands out for its strong growth during the 2008-09 recession. This sets it apart from other industries covered in the Winter 2010 edition of The Conference Board of Canada's Canadian Industrial Profile Service - chemicals, plastic and rubber products, non-metallic mineral products, and computer and electronic products, which will take at least a couple of years to return to pre-recession production, revenue and profit levels.
A new position statement on the use of hormone therapy (HT) for menopausal and postmenopausal women from The North American Menopause Society has been published online today in the Society's journal, Menopause.
Euthymics Bioscience, Inc. today will present Phase II clinical data demonstrating that its lead product candidate EB-1010, a next-generation antidepressant, is effective for treating major depressive disorder (MDD) based on multiple standard measures of outcome for depression. EB-1010 also improved measures of anhedonia, a hallmark symptom of MDD, which is characterized by the inability to experience pleasure.
Almost half of U.S. youth who experience violence, abuse or crime have had at least one of their victimizations known to school, police or medical authorities, according to a report in the January issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.
› Verified 9 days ago
Christopher R Takala, DO Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 9000 W Wisconsin Ave, Pediatric Psychiatry, Milwaukee, WI 53226 Phone: 414-607-5280 | |
Mr. Joseph S. Goveas, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1155 N Mayfair Rd, Department Of Psychiatry, Milwaukee, WI 53226 Phone: 414-955-8900 Fax: 414-955-6285 | |
Dr. Bhupendra O Khatri, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3237 S 16th St, Milwaukee, WI 53215 Phone: 414-769-4040 Fax: 414-769-4041 | |
Joshua E Medow, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Neurocritical Care, Milwaukee, WI 53226 Phone: 414-805-8710 Fax: 414-805-1101 | |
Gina G Negrette, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 820 N Plankinton Ave, Milwaukee, WI 53203 Phone: 414-273-1991 | |
Dr. John Pankiewicz, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 821 W State St, Suite 504, Milwaukee, WI 53233 Phone: 414-278-4690 Fax: 414-223-1817 | |
Biana Kotlyar, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2323 N Lake Dr, 1st Floor, Milwaukee, WI 53211 Phone: 414-291-1620 Fax: 414-291-5969 |